journal article·2018-07Open access

Engineering Whole Mammalian Cells for Target‐Cell‐Specific Invasion/Fusion

Ryosuke Kojima, Martin Fussenegger

Advanced Science· Volume 5· Issue 7

Abstract

Abstract Live mammalian cells are equipped with a synthetic cell invasion system that enables their target‐specific insertion into other live mammalian cells. By conjugating RhoA activator to a transmembrane protein that is segregated from cell–cell interface when specific cell contact occurs, polarization of RhoA activity is synthetically induced inside the cells in response to specific cell contact. This polarization is a sufficient condition for invader cells to selectively penetrate cells expressing a target antigen. Further, when an acid‐responsive fusogenic protein is expressed on invader cells, invader/receiver cell fusion occurs after invasion, and the invader's intracellular contents are released into the recipient's cytosol. It is shown that this system can be used for specific cell ablation. This synthetic‐biology‐inspired cell invasion/fusion system might open the door to using whole mammalian cells for cargo delivery purposes or for ablation of a specific cell type.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Viral Infectious Diseases and Gene Expression in Insects · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biosystems Science and Engineering (D‐BSSE) ETH Zurich Mattenstrasse 26 4058 Basel Switzerland

Graduate School of Medicine The University of Tokyo 7‐3‐1 Hongo Bunkyo‐ku Tokyo 113‐0033 Japan

Faculty of Science University of Basel Mattenstrasse 26 4058 Basel Switzerland

Funding

European Research Council

References (21)

Show source-provided references
1. 10.1007/s00018-016-2207-010.1007/s00018-016-2207-0 ↗
2. 10.1038/nrm250410.1038/nrm2504 ↗
3. 10.1016/j.cell.2007.10.04010.1016/j.cell.2007.10.040 ↗
4. 10.1038/cr.2008.6410.1038/cr.2008.64 ↗
5. 10.1126/scisignal.200512310.1126/scisignal.2005123 ↗
6. 10.7554/eLife.0278610.7554/eLife.02786 ↗
7. 10.1038/cr.2014.13710.1038/cr.2014.137 ↗
8. 10.1038/ni87710.1038/ni877 ↗
9. 10.1038/nature1122010.1038/nature11220 ↗
10. 10.1038/nchembio.249810.1038/nchembio.2498 ↗
11. 10.1038/nbt110110.1038/nbt1101 ↗
12. 10.1021/sb300046810.1021/sb3000468 ↗
13. 10.1038/srep1469310.1038/srep14693 ↗
14. 10.1146/annurev-pharmtox-010611-13465410.1146/annurev-pharmtox-010611-134654 ↗
15. 10.1080/14712598.2016.119617910.1080/14712598.2016.1196179 ↗
16. Ramdasi S. · Int. J. Hematol. Oncol. Stem Cell Res. · 2015 · 9 · 95
17. 10.1158/1078-0432.CCR-09-305710.1158/1078-0432.CCR-09-3057 ↗
18. 10.1093/nar/gnj01410.1093/nar/gnj014 ↗
19. 10.1111/j.1349-7006.2008.00977.x10.1111/j.1349-7006.2008.00977.x ↗
20. 10.1038/srep0902110.1038/srep09021 ↗
21. 10.1016/j.cell.2016.01.01210.1016/j.cell.2016.01.012 ↗